ANI Pharmaceuticals Inc (ANIP)
55.82
+0.72
(+1.31%)
USD |
NASDAQ |
Nov 21, 16:00
55.82
0.00 (0.00%)
After-Hours: 20:00
ANI Pharmaceuticals Market Cap: 1.173B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.158B |
| November 19, 2024 | 1.170B |
| November 18, 2024 | 1.161B |
| November 15, 2024 | 1.189B |
| November 14, 2024 | 1.238B |
| November 13, 2024 | 1.257B |
| November 12, 2024 | 1.282B |
| November 11, 2024 | 1.298B |
| November 08, 2024 | 1.291B |
| November 07, 2024 | 1.227B |
| November 06, 2024 | 1.227B |
| November 05, 2024 | 1.205B |
| November 04, 2024 | 1.177B |
| November 01, 2024 | 1.223B |
| October 31, 2024 | 1.206B |
| October 30, 2024 | 1.233B |
| October 29, 2024 | 1.243B |
| October 28, 2024 | 1.221B |
| October 25, 2024 | 1.229B |
| October 24, 2024 | 1.249B |
| October 23, 2024 | 1.244B |
| October 22, 2024 | 1.266B |
| October 21, 2024 | 1.249B |
| October 18, 2024 | 1.271B |
| October 17, 2024 | 1.267B |
| Date | Value |
|---|---|
| October 16, 2024 | 1.257B |
| October 15, 2024 | 1.235B |
| October 14, 2024 | 1.233B |
| October 11, 2024 | 1.204B |
| October 10, 2024 | 1.161B |
| October 09, 2024 | 1.195B |
| October 08, 2024 | 1.197B |
| October 07, 2024 | 1.177B |
| October 04, 2024 | 1.218B |
| October 03, 2024 | 1.197B |
| October 02, 2024 | 1.212B |
| October 01, 2024 | 1.253B |
| September 30, 2024 | 1.257B |
| September 27, 2024 | 1.236B |
| September 26, 2024 | 1.226B |
| September 25, 2024 | 1.205B |
| September 24, 2024 | 1.231B |
| September 23, 2024 | 1.263B |
| September 20, 2024 | 1.255B |
| September 19, 2024 | 1.270B |
| September 18, 2024 | 1.284B |
| September 17, 2024 | 1.263B |
| September 16, 2024 | 1.182B |
| September 13, 2024 | 1.230B |
| September 12, 2024 | 1.181B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
292.51M
Minimum
Nov 06 2020
1.462B
Maximum
Mar 27 2024
742.19M
Average
664.20M
Median
Market Cap Benchmarks
| Windtree Therapeutics Inc | 0.2971M |
| Allogene Therapeutics Inc | 442.41M |
| AIM ImmunoTech Inc | 13.47M |
| Protalix BioTherapeutics Inc | 122.97M |
| Armata Pharmaceuticals Inc | 75.98M |
Market Cap Related Metrics
| PS Ratio | 1.946 |
| Price to Book Value | 2.890 |
| Price to Free Cash Flow | 14.68 |
| Price | 55.82 |
| Earnings Yield | -1.02% |
| Operating PE Ratio | 112.59 |